Skip to content

Clinical trials

Recruiting Phase 1/2 Neuroblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 1/2 Status: Recruiting Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20212
20221
20232
20245
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Milton S. Hershey Medical Center2
Ascentage Pharma Group Inc.1
Beijing Biotech1
Children's Oncology Group1
Fundación de investigación HM1
Hadassah Medical Organization1
Merck Sharp & Dohme LLC1
National Cancer Institute (NCI)1
Princess Maxima Center for Pediatric Oncology1
Roberto Chiarle1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma17
Osteosarcoma7
Sarcoma, Ewing6
Rhabdomyosarcoma4
Sarcoma, Synovial4
Recurrence3
Rhabdoid Tumor3
Sarcoma3
Wilms Tumor3
Desmoplastic Small Round Cell Tumor2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.